WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company working to make daily pills a thing of the past, today announced it has dosed the first participant ...
Lyndra Therapeutics said today it has won a $13 million grant from the Bill and Melinda Gates Foundation toward development of a once-a-month oral contraceptive—the company’s first foray into women’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results